Use of Tissue Plasminogen Activator in the Clearance of Chronic Subdural Hematomas

NCT05491356 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hematoma, Subdural
Fibrinolytic; Hemorrhage

Interventions

DRUG: Tissue Plasminogen Activator
DRUG: Placebo

Sponsor

Hamilton Health Sciences Corporation